On June 13, Catalyst President Nancy Bradish Myers will present on PDUFA and other user fee agreements, and their impact on drug competition.

Ms. Myers will be a featured speaker for the FDANews webinar, “Impact: FDA User Fees, Drug Competition and Pricing – An Inside View.” She will explore how user fee agreements have driven competition – for branded products, generics and biosimilars – and how Commissioner Scott Gottlieb’s agenda is designed to promote competition.